News
Investors in Invesco QQQ Trust ETF (NASDAQ:QQQ) suffered a steep pullback in August as sellers digested the technology-led ETF (50% weighting), sending it down...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly...
News
Wipro Limited (NYSE:WIT) Q3 2025 Results Conference Call January 17, 2025 8:30 AM ET Company Participants Dipak Bohra – Senior Vice President, Corporate Treasurer...
News
This article was written by Follow Victor Dergunov is an independent investor and author with 20 years experience. He preaches diversification and shares investment...
News
Editor’s note: Seeking Alpha is proud to welcome Alex Leeder as a new contributor. It’s easy to become a Seeking Alpha contributor and earn...
News
Rapid Recap Since I penned my analysis of Samsara (NYSE:IOT) titled Inflection Quarter, the stock has been on a tear. Author’s work on Samsara...
News
Investment Thesis GitLab (NASDAQ:GTLB) will report its fiscal Q2 2024 results on Tuesday after hours. I make the case that GitLab is well-positioned with...
News
Wallenius Wilhelmsen (OTCPK:WAWIF)(OTCPK:WILWY) is a RoRo shipping company primarily that has been benefiting from the return to normal in car exports and trade in...
News
Realty Income (NYSE:O) has underperformed the broader market by a wide margin over the last several years. O is widely regarded as one of...
News
I used to relish going back to school. Although I was sad that summer was over, I loved the idea of new books and...
News
“Our wisest long-term investment is not in the dirty polluting fossil fuels from the past, but in the clean energy of the future.” –...
News
Staid Business, But An Impressive Dividend Profile So Far Hooker Furnishings Corporation (HOFT) is a Virginia-based company that is involved in the business of...
News
Introduction Zymeworks (NASDAQ:ZYME) is a biotech firm dedicated to crafting novel, multifunctional biotherapeutics, especially for challenging cancers and diseases. Their primary product, zanidatamab, is...
